NDC properties for NDC 9 0143-9659
NDC item 00143965901
| NDC 9 | 0143-9659 |
|---|---|
| NDC 10 | 0143-9659-01 |
| NDC Item | 00143965901 |
| packaging | 1 mL in 1 VIAL (0143-9659-01) |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-05-01 |
| Marketing status | ACTIVE |
NDC item 00409656201
| NDC 9 | 0409-6562 |
|---|---|
| NDC 10 | 0409-6562-01 |
| NDC Item | 00409656201 |
| packaging | 1 VIAL in 1 CARTON (0409-6562-01) / 1 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
NDC item 00409656202
| NDC 9 | 0409-6562 |
|---|---|
| NDC 10 | 0409-6562-02 |
| NDC Item | 00409656202 |
| packaging | 1 VIAL in 1 CARTON (0409-6562-02) / 1 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2016-08-01 |
| Marketing effective time low | 2018-01-17 |
| Marketing status | COMPLETED |
NDC item 00517183001
| NDC 9 | 0517-1830 |
|---|---|
| NDC 10 | 0517-1830-01 |
| NDC Item | 00517183001 |
| packaging | 1 VIAL in 1 BOX (0517-1830-01) / 1 mL in 1 VIAL |
| ANDA | ANDA207742 |
| DCSA | CIII |
| Labeler | American Regent, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-07-19 |
| Marketing status | ACTIVE |
NDC item 00574082001
| NDC 9 | 0574-0820 |
|---|---|
| NDC 10 | 0574-0820-01 |
| NDC Item | 00574082001 |
| packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-01) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA040530 |
| DCSA | CIII |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-12-21 |
| Marketing status | ACTIVE |
NDC item 00574082701
| NDC 9 | 0574-0827 |
|---|---|
| NDC 10 | 0574-0827-01 |
| NDC Item | 00574082701 |
| packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-01) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-05-01 |
| Marketing status | ACTIVE |
NDC item 47781091193
| NDC 9 | 47781-911 |
|---|---|
| NDC 10 | 47781-911-93 |
| NDC Item | 47781091193 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (47781-911-93) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA207742 |
| DCSA | CIII |
| Labeler | Alvogen Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-11-02 |
| Marketing status | ACTIVE |
NDC item 50090758400
| NDC 9 | 50090-7584 |
|---|---|
| NDC 10 | 50090-7584-0 |
| NDC Item | 50090758400 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (50090-7584-0) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA215351 |
| DCSA | CIII |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-01 |
| Marketing status | ACTIVE |
NDC item 50090758500
| NDC 9 | 50090-7585 |
|---|---|
| NDC 10 | 50090-7585-0 |
| NDC Item | 50090758500 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (50090-7585-0) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA215351 |
| DCSA | CIII |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-01 |
| Marketing status | ACTIVE |
NDC item 52536062501
| NDC 9 | 52536-625 |
|---|---|
| NDC 10 | 52536-625-01 |
| NDC Item | 52536062501 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (52536-625-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA206368 |
| COLORTEXT | white(or creamy white) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Wilshire Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-05-31 |
| Marketing status | ACTIVE |
NDC item 55150027701
| NDC 9 | 55150-277 |
|---|---|
| NDC 10 | 55150-277-01 |
| NDC Item | 55150027701 |
| packaging | 1 VIAL, GLASS in 1 CARTON (55150-277-01) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA211817 |
| DCSA | CIII |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
NDC item 62756001540
| NDC 9 | 62756-015 |
|---|---|
| NDC 10 | 62756-015-40 |
| NDC Item | 62756001540 |
| packaging | 1 VIAL in 1 CARTON (62756-015-40) / 1 mL in 1 VIAL |
| ANDA | ANDA201720 |
| DCSA | CIII |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
NDC item 63629870501
| NDC 9 | 63629-8705 |
|---|---|
| NDC 10 | 63629-8705-1 |
| NDC Item | 63629870501 |
| packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-05-01 |
| Marketing status | ACTIVE |
NDC item 64980046799
| NDC 9 | 64980-467 |
|---|---|
| NDC 10 | 64980-467-99 |
| NDC Item | 64980046799 |
| packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (64980-467-99) / 1 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA207742 |
| DCSA | CIII |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-12-01 |
| Marketing status | COMPLETED |
NDC item 68071383501
| NDC 9 | 68071-3835 |
|---|---|
| NDC 10 | 68071-3835-1 |
| NDC Item | 68071383501 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68071-3835-1) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA207742 |
| DCSA | CIII |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-11-02 |
| Marketing status | ACTIVE |
NDC item 69097053731
| NDC 9 | 69097-537 |
|---|---|
| NDC 10 | 69097-537-31 |
| NDC Item | 69097053731 |
| packaging | 1 mL in 1 VIAL, GLASS (69097-537-31) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
NDC item 69097080232
| NDC 9 | 69097-802 |
|---|---|
| NDC 10 | 69097-802-32 |
| NDC Item | 69097080232 |
| packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-32) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-03-26 |
| Marketing status | ACTIVE |
NDC item 70700028922
| NDC 9 | 70700-289 |
|---|---|
| NDC 10 | 70700-289-22 |
| NDC Item | 70700028922 |
| packaging | 1 VIAL in 1 CARTON (70700-289-22) / 1 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
NDC item 71205028901
| NDC 9 | 71205-289 |
|---|---|
| NDC 10 | 71205-289-01 |
| NDC Item | 71205028901 |
| packaging | 1 mL in 1 VIAL (71205-289-01) |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-05-01 |
| Marketing status | ACTIVE |
NDC item 71335247001
| NDC 9 | 71335-2470 |
|---|---|
| NDC 10 | 71335-2470-1 |
| NDC Item | 71335247001 |
| packaging | 1 VIAL, GLASS in 1 CARTON (71335-2470-1) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA040530 |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-12-21 |
| Marketing status | ACTIVE |
NDC item 72162111902
| NDC 9 | 72162-1119 |
|---|---|
| NDC 10 | 72162-1119-2 |
| NDC Item | 72162111902 |
| packaging | 1 VIAL, GLASS in 1 CARTON (72162-1119-2) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-05-01 |
| Marketing status | ACTIVE |
NDC item 72162234802
| NDC 9 | 72162-2348 |
|---|---|
| NDC 10 | 72162-2348-2 |
| NDC Item | 72162234802 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (72162-2348-2) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA206368 |
| COLORTEXT | white(or creamy white) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-05-31 |
| Marketing status | ACTIVE |
NDC item 72162234804
| NDC 9 | 72162-2348 |
|---|---|
| NDC 10 | 72162-2348-4 |
| NDC Item | 72162234804 |
| packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (72162-2348-4) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206368 |
| COLORTEXT | white(or creamy white) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-05-31 |
| Marketing status | ACTIVE |
NDC item 72162237502
| NDC 9 | 72162-2375 |
|---|---|
| NDC 10 | 72162-2375-2 |
| NDC Item | 72162237502 |
| packaging | 1 VIAL, GLASS in 1 CARTON (72162-2375-2) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA040530 |
| DCSA | CIII |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-12-21 |
| Marketing status | ACTIVE |
NDC item 72603028601
| NDC 9 | 72603-286 |
|---|---|
| NDC 10 | 72603-286-01 |
| NDC Item | 72603028601 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-286-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA215351 |
| DCSA | CIII |
| Labeler | NorthStar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-01 |
| Marketing status | ACTIVE |
NDC item 76420074601
| NDC 9 | 76420-746 |
|---|---|
| NDC 10 | 76420-746-01 |
| NDC Item | 76420074601 |
| packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-01) / 1 mL in 1 VIAL, GLASS |
| ANDA | ANDA091244 |
| DCSA | CIII |
| Labeler | Asclemed USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-03-26 |
| Marketing status | ACTIVE |
NDC item 76420074701
| NDC 9 | 76420-747 |
|---|---|
| NDC 10 | 76420-747-01 |
| NDC Item | 76420074701 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (76420-747-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA207742 |
| DCSA | CIII |
| Labeler | Asclemed USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-11-02 |
| Marketing status | ACTIVE |